Sysmex Europe
Menu

Cancer is a challenge best faced together

Each day, over nine thousand people in Europe are newly diagnosed with cancer. The growing understanding of cancer pathophysiology, and the systematic development of diagnostic and therapeutic solutions are leading to improved survival rates and quality of life for many.

To continue this trend, medical disciplines and specialists are merging expertise and experience. They are stronger together.

At Sysmex, we too contribute to improving patient care in cancer management. With profound scientific knowledge and an understanding of clinical needs, we work closely with our partners to deliver innovative diagnostic solutions and therapeutic support that, wherever possible, address patients and their therapy individually.

Through greater efficiency in clinics, diagnostics that take into account patient wellbeing, and by reducing side- and post effects, we’re lighting the way in cancer management.

Our Life Science solutions

CALiaGold

CALiaGold

Quantitative calprotectin measurement on your dedicated stand-alone faecal analyser

Details
CytoCell® IVDR probes

CytoCell® IVDR probes

IVDR-certified FISH probes 

Details
FOB Gold

FOB Gold

Quantitative haemoglobin measurement on your dedicated stand-alone faecal analyser or TLA

Details
MammaTyper®

MammaTyper®

Comprehensive molecular subtyping of breast cancer patients

Details
Microarrays (CytoSure)

Microarrays (CytoSure)

Microarrays for cytogenetics, rare diseases and cancer research

Details
OSNA in breast cancer

OSNA in breast cancer

More differentiated information to fine-tune your treatment decision

Details
OSNA in colorectal cancer

OSNA in colorectal cancer

The best therapy decision relies on accurate staging

Details
OSNA in gastric cancer

OSNA in gastric cancer

Informed decisions for therapy depend on accurate staging

Details
OSNA in gynaecological

OSNA in gynaecological

Lymph node assessment beyond ultra-staging

Details
  1. 1
  2. 2
  3. 3
Copyright © Sysmex Europe SE. All rights reserved.